GHRS
NASDAQ · Pharmaceuticals
Gh Research Plc
$24.58
-0.02 (-0.08%)
Open$24.68
Previous Close$24.60
Day High$24.93
Day Low$24.33
52W High$25.94
52W Low$11.32
Volume—
Avg Volume256.0K
Market Cap1.52B
P/E Ratio—
EPS$-0.91
SectorPharmaceuticals
Analyst Ratings
Strong Buy
15 analysts
Price Target
+96.2% upside
Current
$24.58
$24.58
Target
$48.23
$48.23
$34.28
$48.23 avg
$66.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 289.57M | 263.52M | 305.92M |
| Net Income | 46.13M | 45.80M | 47.46M |
| Profit Margin | 15.9% | 17.4% | 15.5% |
| EBITDA | 85.32M | 72.54M | 88.44M |
| Free Cash Flow | 28.26M | 23.23M | 28.03M |
| Rev Growth | +11.0% | +19.2% | +2.7% |
| Debt/Equity | 0.68 | 0.55 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |